W. R. Grace & — Investor Presentation (August 2020)
25 slides from W. R. Grace &'s investor presentation, Aug 26, 2020
Slide 1: Investor Presentation August 2020
Investor Presentation August 2020
Slide 2: Disclaimer: Statement Regarding Safe Harbor For Forward-Looking Statements
DISCLAIMER Statement Regarding Safe Harbor For Forward-Looking Statements This presentation and the exhibits hereto contain forward-looking statements, that is, information related to future, not past, events. Such statements generally include the words “believes,” “plans,” “intends,” “targets,” “wi
Slide 3: Grace Overview & Strategy
Grace Overview & Strategy GRACE Talent | Technology | Trust™
Slide 4: Grace at a Glance
GRACE AT A GLANCE (NYSE:GRA) The Leading Global Supplier of Process Catalysts and Specialty Silicas Materials Technologies Catalyst Technologies ~$3.0B $2B $0.5B 19% Sales $2.0B2 81% Sales2 Market Cap1 2019 Sales Traditional Fuels 24% PetroChem Feedstocks 8% ~80% >72% of sales in Chemical Process 7%
Slide 5: Strategic Update
STRATEGIC UPDATE 1 Invest to accelerate • Sustaining strategic growth initiatives to accelerate long-term growth and extend competitive advantages growth and extend our competitive advantages – Maintaining R&D spending; focused on technology and innovation • Pandemic does not change the value of our
Slide 6: Compelling Investment Thesis
COMPELLING INVESTMENT THESIS • Increasing demand for high-performance plastics, petrochemical feedstocks, and clean transportation fuels Enduring Growth Drivers • Rising living standards and growing middle class incomes • Growing global focus on stricter environmental standards, improving health and
Slide 7: Leading Positions in High-Value End Markets Tied to Positive, Long-Term Trends
LEADING POSITIONS IN HIGH-VALUE END MARKETS TIED TO POSITIVE, LONG-TERM TRENDS ▪ Independent Polypropylene ▪ Hydroprocessing Process Technology Licensing ▪ Hydrocracking of sales in segments # ▪ Polyolefin Catalysts ▪ Specialty Silica Gel ~80% where we are #1 or #2 1 ▪ FCC Catalysts Specialty Cataly
Slide 8: Grace Products Contribute to Our Customers' Sustainability Objectives
GRACE PRODUCTS CONTRIBUTE TO OUR CUSTOMERS’ SUSTAINABILITY OBJECTIVES 2019 Sales Examples of Grace Products and Benefits • High-performing PP catalysts for lightweighting auto parts to improve fuel economy Improving our • Custom single-site PE catalysts for downgauging packaging to reduce plastics u
Slide 9: Leveraging the Grace Value Model (GVM)
LEVERAGING THE GRACE VALUE MODEL (GVM) At the company level, we focus on portfolio, strategic position, and capital allocation • We invest to grow our businesses, improve our strategic position, and maintain our high ROIC At the business level, we focus on customers, innovation, growth, and profitab
Slide 10: Financial Review & Capital Allocation Framework
Financial Review & Capital Allocation Framework
Slide 11: 3Q20 Update
3Q20 UPDATE 3Q20 Planning Assumptions Refining Market Commentary Impact of Recent Announcements of U.S. Refinery Closures Sales: Planning for 3Q sales to be down 10%-13% YOY; sequentially, sales roughly flat vs. 2Q driven by: • No Grace FCC catalysts customers impacted by recent announcements – FCC
Slide 12: 3Q20 Segment Demand Assessment
3Q20 SEGMENT DEMAND ASSESSMENT 2Q20 Sales Demand Factor Demand Outlook Inventory levels Commentary Transportation Fuels & 2Q20 → 3Q20 2Q20 3Q20 Petrochemical feedstocks • Gasoline demand down 30% y/y in 2Q Sequential Outlook Refined Refining on July 30th • Refinery utilization bottomed in April and
Slide 13: Strong Financial Position
STRONG FINANCIAL POSITION Ample Liquidity – Strong cash flow in 2Q20 led to increase in cash and Cash and >$680M ~$250M liquidity; liquidity up approximately $75M since end of 1Q20 Liquidity1 Liquidity Cash-on-Hand – Over $680M in available liquidity, including roughly $250M of cash-on-hand1 Strong
Slide 14: Disciplined Capital Allocation
DISCIPLINED CAPITAL ALLOCATION CAPITAL ALLOCATION FRAMEWORK INVEST IN ORGANIC GROWTH PURSUE STRATEGIC ACQUISITIONS DIVIDENDS RETURN CASH TO SHAREHOLDERS BUYBACKS NEAR-TERM SHIFT IN PRIORITIES IN RESPONSE TO COVID-19 2x - 3x – Lowered capital spending; maintaining R&D and Target targeted strategic in
Slide 15: Supplemental Information
Supplemental Information GRACE Talent | Technology | Trust™
Slide 16: Grace's Response to COVID-19 Pandemic
GRACE’S RESPONSE TO COVID-19 PANDEMIC Committed to health and safety of our employees Grace Pharma Joins the Fight Against COVID-19 Acted early and effectively to implement new DETECT safety protocols across global operations Following guidance of public health authorities and local authorities Our
Slide 17: 2Q20 Highlights
2Q20 HIGHLIGHTS 2Q20 Actual (y/y) 2Q20 Overview • Sales and earnings better than we expected Sales – Customer inventory corrections less than expected in 2Q; planning for impact to shift to 3Q $419M • Exceptional cash flow performance in the quarter driven by decisive actions to mitigate the effects
Slide 18: Immediate and Decisive Actions to Minimize Financial Impacts
IMMEDIATE AND DECISIVE ACTIONS TO MINIMIZE FINANICAL IMPACTS Focus on Cash and Managing Costs 2Q20 Adj. Gross Margin Bridge 42.1% Full-Year Full-Year Target Target as of as of 34.1% Actions 4/30/2020 7/30/2020 Lower capital spending $35-40M ~$40M Improving working capital $35-40M $45-50M ** Chart is
Slide 19: Refining Technologies Manufacturing Operations and Global Footprint
REFINING TECHNOLOGIES MANUFACTURING OPERATIONS AND GLOBAL FOOTPRINT • In connection with our on-going operating excellence initiatives, we have accelerated the implementation of the GMS at our three hydroprocessing catalysts manufacturing sites, including key organizational changes and optimization
Slide 20: Appendix: Definitions and Reconciliations of Non-GAAP Measures
Appendix: Definitions and Reconciliations of Non-GAAP Measures Non-GAAP Financial Measures (A) In the above, Grace presents financial information in accordance with U.S. generally accepted accounting principles (U.S. GAAP), as well as the non-GAAP financial information described below. Grace believe
Slide 21: Appendix: Definitions and Reconciliations of Non-GAAP Measures (continued)
Appendix: Definitions and Reconciliations of Non-GAAP Measures (continued) Non-GAAP Financial Measures Adjusted EBIT, Adjusted EBITDA, Adjusted EBIT Return On Invested Capital, Adjusted Gross Margin, Adjusted EPS, Adjusted Free Cash Flow, Net Sales, constant currency, and Organic sales growth do not
Slide 22: Appendix: Definitions and Reconciliations of Non-GAAP Measures (continued)
Appendix: Definitions and Reconciliations of Non-GAAP Measures (continued) Non-GAAP Financial Measures (C) Certain pension costs include only ongoing costs recognized quarterly, which include service and interest costs, expected returns on plan assets, and amortization of prior service costs/credits
Slide 23: Appendix: Reconciliation of Non-GAAP Financial Measures (continued)
Appendix: Reconciliation of Non-GAAP Financial Measures (continued) Adjusted EBIT by Operating Segment(A)(B): 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Catalysts Technologies segment operating income $ 467.4 $ 101.7 $ 125.8 $ 104.7 $ 135.2 $ 82.0 $ 71.7 Materials Technologies segment oper
Slide 24: Appendix: Reconciliation of Non-GAAP Financial Measures (continued)
Appendix: Reconciliation of Non-GAAP Financial Measures (continued) Adjusted Free Cash Flow(A): YTD 2Q 2020 YTD 2Q 2019 Net cash provided by (used for) operating activities $ 184.6 $ 144.9 Cash paid for capital expenditures (95.0) (101.5) Free Cash Flow 89.6 43.4 Cash paid for legacy matters 12.3 7.
Slide 25: Appendix: Reconciliation of Non-GAAP Financial Measures (continued)
Appendix: Reconciliation of Non-GAAP Financial Measures (continued) Three Months Ended June 30, 2020 2019 (In millions, except per share amounts) Pre-Tax Tax Effect After Tax Per Share Pre-Tax Tax Effect After Tax Per Share Diluted earnings per share $ (0.11) $ 1.14 Restructuring and repositioning e